165 related articles for article (PubMed ID: 36437222)
41. Outcomes of Artificial Urinary Sphincter Implantation in Patients with Detrusor Underactivity and Postprostatectomy Incontinence.
Han KH; Kim JC; Bae WJ; Choi JB; Koh JS; Cho KJ
Urol J; 2023 Jul; 20(4):234-239. PubMed ID: 36906798
[TBL] [Abstract][Full Text] [Related]
42. The other bladder syndrome: underactive bladder.
Miyazato M; Yoshimura N; Chancellor MB
Rev Urol; 2013; 15(1):11-22. PubMed ID: 23671401
[TBL] [Abstract][Full Text] [Related]
43. The effect of extracorporeal shock wave therapy in acute traumatic spinal cord injury on motor and sensory function within 6 months post-injury: a study protocol for a two-arm three-stage adaptive, prospective, multi-center, randomized, blinded, placebo-controlled clinical trial.
Leister I; Mittermayr R; Mattiassich G; Aigner L; Haider T; Machegger L; Kindermann H; Grazer-Horacek A; Holfeld J; Schaden W
Trials; 2022 Apr; 23(1):245. PubMed ID: 35365190
[TBL] [Abstract][Full Text] [Related]
44. Randomized controlled trial of intravesical electrical stimulation for underactive bladder.
Liao L; Deng H; Chen G; Chen H; Huang M; Xie K; Wei X; Xu Z; Huang B; Chong T; Chen Q; Xiao H; Huang Z; Jiang H; Jing H
BJU Int; 2023 Mar; 131(3):321-329. PubMed ID: 36084065
[TBL] [Abstract][Full Text] [Related]
45. New therapeutic directions to treat underactive bladder.
Chai TC; Kudze T
Investig Clin Urol; 2017 Dec; 58(Suppl 2):S99-S106. PubMed ID: 29279882
[TBL] [Abstract][Full Text] [Related]
46. [Functional changes during the voiding phase in males with non-neurogenic detrusor underactivity undergoing bladder catheterization.].
Vírseda-Chamorro M; Salinas-Casado J; Méndez-Rubio S; Barroso Manso Á; Esteban-Fuertes M
Arch Esp Urol; 2019 Jul; 72(6):564-569. PubMed ID: 31274121
[TBL] [Abstract][Full Text] [Related]
47. A cross-sectional study in the USA of the epidemiology and quality of life of underactive bladder symptoms.
Faraj K; Doo F; Boura J; Vereecke A; Chancellor MB
Int Urol Nephrol; 2016 Nov; 48(11):1797-1802. PubMed ID: 27473156
[TBL] [Abstract][Full Text] [Related]
48. Extracorporeal shock wave therapy in Peyronie's disease: results of a placebo-controlled, prospective, randomized, single-blind study.
Hatzichristodoulou G; Meisner C; Gschwend JE; Stenzl A; Lahme S
J Sex Med; 2013 Nov; 10(11):2815-21. PubMed ID: 23898925
[TBL] [Abstract][Full Text] [Related]
49. Sacral neuromodulation in patients with detrusor underactivity: Is biological sex an indicator?
Onur R; Tayebi S; Salehi-Pourmehr H; Jahantabi E; Perrouin-Verbe MA; Naseri C; Hajebrahimi S; Hashim H
Neurourol Urodyn; 2022 Mar; 41(3):847-859. PubMed ID: 35181913
[TBL] [Abstract][Full Text] [Related]
50. Urodynamics tests for the diagnosis and management of bladder outlet obstruction in men: the UPSTREAM non-inferiority RCT.
Lewis AL; Young GJ; Selman LE; Rice C; Clement C; Ochieng CA; Abrams P; Blair PS; Chapple C; Glazener CM; Horwood J; McGrath JS; Noble S; Taylor GT; Lane JA; Drake MJ
Health Technol Assess; 2020 Sep; 24(42):1-122. PubMed ID: 32902375
[TBL] [Abstract][Full Text] [Related]
51. Clinical and urodynamic characteristics of underactive bladder: Data analysis of 1726 cases from a single center.
Li X; Liao LM; Chen GQ; Wang ZX; Lu TJ; Deng H
Medicine (Baltimore); 2018 Jan; 97(3):e9610. PubMed ID: 29504988
[TBL] [Abstract][Full Text] [Related]
52. Extracorporeal shock wave therapy for the treatment of chronic pelvic pain syndrome in males: a randomised, double-blind, placebo-controlled study.
Zimmermann R; Cumpanas A; Miclea F; Janetschek G
Eur Urol; 2009 Sep; 56(3):418-24. PubMed ID: 19372000
[TBL] [Abstract][Full Text] [Related]
53. Effects of tadalafil versus silodosin on voiding function in male patients with non-neurogenic detrusor underactivity: A comparative study using propensity score matching.
Matsukawa Y; Majima T; Funahashi Y; Fujita T; Ishida S; Kato M; Gotoh M
Int J Urol; 2021 Apr; 28(4):411-416. PubMed ID: 33393153
[TBL] [Abstract][Full Text] [Related]
54. Signs and Symptoms of Detrusor Underactivity: An Analysis of Clinical Presentation and Urodynamic Tests From a Large Group of Patients Undergoing Pressure Flow Studies.
Gammie A; Kaper M; Dorrepaal C; Kos T; Abrams P
Eur Urol; 2016 Feb; 69(2):361-9. PubMed ID: 26318706
[TBL] [Abstract][Full Text] [Related]
55. Urodynamic characteristics of detrusor underactivity in women with voiding dysfunction.
Yang TH; Chuang FC; Kuo HC
PLoS One; 2018; 13(6):e0198764. PubMed ID: 29924821
[TBL] [Abstract][Full Text] [Related]
56. Detrusor underactivity in women: A current understanding.
Hartigan SM; Reynolds WS; Dmochowski RR
Neurourol Urodyn; 2019 Nov; 38(8):2070-2076. PubMed ID: 31432566
[TBL] [Abstract][Full Text] [Related]
57. Recovery of Voiding Efficiency and Bladder Function in Male Patients With Non-neurogenic Detrusor Underactivity After Transurethral Bladder Outlet Surgery.
Lee KH; Kuo HC
Urology; 2019 Jan; 123():235-241. PubMed ID: 30308261
[TBL] [Abstract][Full Text] [Related]
58. Variability of post-void residual urine volume and bladder voiding efficiency in patients with underactive bladder.
Yono M; Ito K; Oyama M; Tanaka T; Irie S; Matsukawa Y; Sekido N; Yoshida M; van Till O; Yamaguchi O
Low Urin Tract Symptoms; 2021 Jan; 13(1):51-55. PubMed ID: 32525267
[TBL] [Abstract][Full Text] [Related]
59. Treatment outcomes of detrusor underactivity in women based on clinical and videourodynamic characteristics.
Chen SF; Jhang JF; Jiang YH; Kuo HC
Int Urol Nephrol; 2022 Jun; 54(6):1215-1223. PubMed ID: 35294677
[TBL] [Abstract][Full Text] [Related]
60. Ultrastructural changes in the underactive bladder.
Ho HC; Hsu YH; Jhang JF; Jiang YH; Kuo HC
Tzu Chi Med J; 2021; 33(4):345-349. PubMed ID: 34760629
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
